U.S. Healthcare Services Stock News

MARA Holdings, Inc. has already reported first-quarter 2026 results showing sales of US$174.61 million versus US$213.88 million a year earlier and a net loss of US$1.26 billion versus US$533.20 million, while outlining a US$1.52 billion deal to acquire Long Ridge Energy & Power and expand into energy-backed AI infrastructure. These developments coincide with US President Donald Trump disclosing a personal equity stake in MARA Holdings, an unprecedented move that links the company’s bitcoin...

Viavi Solutions (NasdaqGS:VIAV) has announced and priced a US$500 million follow on equity offering. The company plans to use the proceeds to repay debt and for general working capital. The transaction represents a significant capital raise relative to the company and marks a material update to its capital structure. Viavi Solutions operates in communications test, measurement, and optical technologies, serving network operators and related customers. For investors, the fresh equity raise...

Nuvalent plans to present pivotal clinical trial data at the 2026 ASCO Annual Meeting. The presentations include neladalkib data in ALK-positive NSCLC that supported a recent FDA NDA submission and an ongoing Phase 3 trial. The company will also share the first clinical look at zidesamtinib in ROS1-positive solid tumors, including early response data. Nuvalent (NasdaqGS:NUVL) is drawing attention ahead of ASCO 2026 as it prepares to showcase data that underpin a recent FDA NDA filing for...

Tapestry (TPR) has just secured a U.S. patent for Mira, its in house AI platform built to connect data across the business and support faster decisions around inventory, assortments and consumer trends. See our latest analysis for Tapestry. The patent news lands as Tapestry’s share price, now at US$139.11, reflects mixed momentum, with a 7 day share price return of 6.81% and a 30 day return that fell 7.57%, while the 1 year total shareholder return of 78.66% points to a strong longer term...

Why Halozyme Therapeutics (HALO) Is Drawing Investor Attention Now Halozyme Therapeutics (HALO) is back on investors’ radar after a period of mixed share performance, with the stock roughly flat over the past month but lower over the past 3 months. See our latest analysis for Halozyme Therapeutics. At around US$68.52, Halozyme’s recent share price moves have been relatively muted, yet the 1 year total shareholder return of 27.48% and 3 year total shareholder return of 106.76% point to longer...

Most biotech stocks working towards a treatment for Parkinson's are already carrying a premium price. These three sit further off the radar, and analysts think the market has them badly wrong.

Stock performance snapshot Manhattan Associates (MANH) has been drawing attention after a mixed run in recent months, with the stock down about 20% year to date and roughly 28% over the past year. Short term performance looks different. The share price eased around 1.8% in the latest session but rose about 4.3% over the past week and has held close to flat over the past month. Over longer periods the picture has been weaker, with total returns declining about 23% over three years and roughly...

Hanover Insurance Group (NYSE:THG) has appointed Patricia A. Norton-Gatto as Principal Accounting Officer. The appointment reflects an internal promotion following Ms. Norton-Gatto’s long tenure and progression within the company. This move affects oversight of the company’s financial reporting and accounting functions, areas closely watched by many investors. For you as an investor, this change sits at the core of how Hanover Insurance Group presents its financial picture. As a property...

Earlier this month, American Homes 4 Rent declared a US$0.33 per share cash dividend on its common stock for the second quarter of 2026, alongside quarterly cash distributions of US$0.36719 per share on its 5.875% Series G and US$0.39063 per share on its 6.250% Series H cumulative redeemable perpetual preferred shares, all payable on June 30, 2026 to shareholders of record on June 15, 2026. These dividend declarations, coming shortly before a broker rating upgrade, highlight how income...

Dover’s Microwave Products Group plans to launch three AI-enabled RF and electronic warfare solutions for Aerospace & Defense at AOC Europe 2026. The new products focus on radio frequency signal identification and electronic warfare capabilities for defense and aerospace customers. The launches expand Dover’s presence in advanced RF and signals intelligence technologies within a key end market. For investors tracking NYSE:DOV, these product launches come as the stock trades at $207.77, with...

Walmart (WMT) opened its Q1 2027 reporting season with investors still focused on its recent run of quarterly results, which saw Q4 2026 revenue at about US$190.7b, basic EPS of US$0.53 and net income of US$4.2b. Over the last year, quarterly revenue moved from roughly US$165.6b in Q1 2026 to US$190.7b in Q4 2026, while basic EPS ranged between US$0.53 and US$0.88 as the retailer cycled through different trading periods. With trailing 12 month earnings growth of 12.6% and profit margins...

BeOne Medicines' BCL-2 inhibitor sonrotoclax (BEQALZI) has received accelerated FDA approval for relapsed or refractory mantle cell lymphoma. The decision marks a key regulatory milestone in hematology oncology for patients whose disease persists or returns after prior treatment. Sonrotoclax is also under review in additional regions and indications across hematologic malignancies. BeOne Medicines, listed as NasdaqGS:ONC, focuses on targeted therapies in hematology oncology, an area where...

In May 2026, Microchip Technology reported strong fiscal Q4 and full-year 2026 results, beating prior earnings guidance, tightening inventory, and returning US$984 million to shareholders via dividends while guiding to higher sales and margins for Q1 2027. Alongside these results, Microchip launched its EX-423 evacuated miniature crystal oscillator for high-reliability markets, underscoring how niche, ruggedized timing products may broaden its reach in defense, communications, and industrial...

If you are wondering whether Booking Holdings at around US$159.68 is starting to look attractively priced or still has further to fall, the valuation picture is the key piece to focus on next. The stock has risen about 3.4% over the past week, but is still down around 16.3% over the past month, about 25.0% year to date, and about 24.7% over the last year, set against much stronger gains of 56.6% over three years and 74.2% over five years. Recent moves have come as investors reassess the...

In May 2026, Bath & Body Works, Inc. declared a quarterly dividend of US$0.20 per share, payable on June 19, 2026, with both the ex-dividend and record dates having occurred on June 5, 2026. At the same time, analysts were anticipating lower year-over-year earnings and revenue but had recently revised their profit estimates higher, highlighting a tension between softer sales trends and expectations for an earnings outperformance. Next, we’ll examine how this potential earnings surprise,...

Recent performance snapshot Cushman & Wakefield (CWK) has drawn attention after a period where the stock is down about 12% over the past month and roughly 4% over the past 3 months, despite a positive 1 year total return. See our latest analysis for Cushman & Wakefield. At a share price of $12.82, the stock has seen its short term share price momentum fade. However, the 1 year and 3 year total shareholder returns remain firmly positive, suggesting investors are still weighing growth prospects...

Cohen & Steers recently overhauled its U.S. REIT portfolio, adding and exiting several positions, while also announcing Amit Muni as its next Executive Vice President and Chief Financial Officer, effective June 8, 2026. This combination of portfolio repositioning and a new finance leader signals a potential shift in how the firm manages risk, capital allocation, and future growth priorities. Next, we’ll examine how the appointment of Amit Muni as CFO could influence Cohen & Steers’ existing...

Earlier this month, SharkNinja, Inc. launched the Ninja SLUSHi Twist, a dual-vessel frozen drink machine with independently powered 48‑oz containers, supported by a Snooki and JWoww “SLUSHi Sundays” promotion and limited-edition kits for the first 100 online purchasers at US$399.99. The product’s dual-flavor capability, seasonal focus on summer entertaining, and celebrity-backed social media campaign highlight how SharkNinja is using experiential marketing and differentiated appliances to...

Lowe's Companies (LOW) opened Q1 2027 with total revenue of US$23.1b, basic EPS of US$2.90 and net income of US$1,623m, while same store sales growth came in at 0.6% for the quarter. The company has seen quarterly revenue move from US$20.9b in Q1 2026 to US$23.1b in Q1 2027, with basic EPS shifting from US$2.93 to US$2.90 over the same period. Trailing twelve month net income of US$6.6b on revenue of US$88.4b sets the backdrop for a business where margins and modest same store sales growth...

Ambarella, ticker NasdaqGS:AMBA, has launched a new quarterly Industry Analyst Briefing program focused on edge and physical AI. The first session of this recurring briefing series is scheduled for June 4, 2026. The program is aimed at non financial industry analysts who influence enterprise buyers and OEMs in sectors such as automotive, IoT, security, and robotics. Ambarella enters this new outreach effort with its stock at $83.64, alongside a 39.4% return over the past 30 days and a 32.5%...

Recent return profile and business snapshot Corcept Therapeutics (CORT) has drawn fresh attention after a strong recent share price run, with the stock up 1.1% over the past day, 2.4% over the past week and 32.4% over the past month. Over the past 3 months, the stock is up 71.4%, while the past year shows a total return decline of 21.6%. Longer horizons look different, with total returns of 143.4% over 3 years and 175.4% over 5 years. The company, headquartered in Redwood City, California,...

Why IREN stock is moving now IREN Limited (NasdaqGS:IREN) has been in focus after a series of AI focused moves, including a five year, US$3.4b infrastructure cloud contract with Nvidia and a pivot away from pure Bitcoin mining. See our latest analysis for IREN. The latest 10.15% 1 day share price gain to US$58.06 builds on a 28.54% 30 day share price return and a 45.22% 90 day share price return. The 1 year total shareholder return is extremely high and the 3 year total shareholder return is...

Clover Health Investments recently reported its first-ever positive GAAP net income alongside strong Q1 2026 results, supported by rapid Medicare Advantage membership growth and disciplined cost management. The company also highlighted the growing impact of its Clover Assistant technology, with sustained improvements in medical cost ratios as member cohorts mature, underscoring the role of its software platform in driving operating performance. Next, we will examine how this milestone of...

Ichor Holdings (ICHR) has moved to raise capital, filing a universal shelf registration that covers ordinary shares, preferred stock and warrants, alongside a US$200 million at the market follow on equity offering. See our latest analysis for Ichor Holdings. The share price has eased recently, with a 1 day move down of 0.67% and a 7 day share price return down 12.33%. However, the 90 day share price return of 29.73% and year to date share price return of 220.04% indicate strong momentum. The...